Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2025-12-24 @ 11:33 PM
NCT ID:
NCT03408756
Eligibility Criteria:
Inclusion Criteria:
1. Patients aged more than 18 years with clinical diagnosis of plaque psoriasis
2. Patients with body surface area involvement \> 10 %, PASI \>10, DLQI \>10.
Exclusion Criteria:
1. Hemoglobin \< 8 gm/dl ,Total leukocyte count \< 3500/ mm3, Platelet count \< 100,000/mm3
2. Elevation of hepatic enzymes (alanine aminotransferase \[ALT\], aspartate aminotransferase \[AST\], or γ glutamyl transferase \[GGT\]) to more than twice the upper limit of normal.
3. Hepatitis, active or recurrent, cirrhosis or excessive current alcohol intake .
4. Use of other hepatotoxic drugs by the patient
5. Positive hepatitis B, hepatitis C or HIV serology
6. Pulmonary or extra-pulmonary active tuberculosis
7. Deranged renal function test.
8. Pregnancy or lactation or if patient is planning to conceive during the treatment period.
9. Patient on other immunosuppressive drugs
10. Recent live vaccination
11. Unreliable patient
12. Patients unwilling for monthly follow-ups. -
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03408756
Study Brief:
Protocol Section:
NCT03408756